Shelton frames LTC@Home not as a reinvention of pharmacy practice, but as a formalization and monetization of services pharmacies are already delivering—medication synchronization, adherence packaging, clinical oversight, caregiver support, and coordination with providers. The core issue isn’t capability—it’s structure and reimbursement. Many community pharmacies are بالفعل functioning as LTC providers informally, but without the regulatory designation and billing pathways that unlock consistent revenue.

A major theme in the conversation is conversion strategy. Shelton discusses how pharmacies can transition into LTC@Home providers by aligning operations with compliance standards, documentation requirements, and payer expectations. This includes setting up the right workflows, leveraging technology for med management and reporting, and ensuring staff are trained to operate within an LTC framework. Importantly, these conversions are not out of reach—they are highly achievable with the right guidance, and they allow pharmacies to immediately begin capturing value for existing services.

The financial upside is significant. LTC@Home opens access to enhanced reimbursement models, service-based payments, and stronger payer relationships, especially within Medicare Advantage and managed care environments. Shelton emphasizes that pharmacies are leaving money on the table by not formalizing these services—and that LTC@Home is a direct path to correcting that.

Strategically, this model positions community pharmacy at the center of aging-in-place healthcare, one of the fastest-growing segments in the industry. As more patients remain in their homes rather than institutional settings, pharmacies that adapt to LTC@Home will become essential care hubs—supporting not just medication dispensing, but ongoing clinical and logistical care.

The takeaway is clear: LTC Pharmacy at Home is not just an opportunity—it’s a directional shift for the profession. Pharmacies that move early can differentiate, stabilize revenue, and deepen their role in patient care, while those that delay risk being left behind as the model becomes standard.